{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,20]],"date-time":"2026-06-20T01:47:58Z","timestamp":1781920078472,"version":"3.54.5"},"reference-count":0,"publisher":"American Medical Association (AMA)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Dermatol"],"published-print":{"date-parts":[[2018,4,1]]},"DOI":"10.1001\/jamadermatol.2017.5889","type":"journal-article","created":{"date-parts":[[2018,2,14]],"date-time":"2018-02-14T17:58:07Z","timestamp":1518631087000},"page":"487","source":"Crossref","is-referenced-by-count":10,"title":["Lenalidomide as an Alternative to Thalidomide for Treatment of Recurrent Erythema Multiforme"],"prefix":"10.1001","volume":"154","author":[{"given":"Faustine","family":"Drahy","sequence":"first","affiliation":[{"name":"Department of Dermatology, Assistance Publique\u2013H\u00f4pitaux de Paris, Henri Mondor Hospital, Cr\u00e9teil, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saskia","family":"Ingen-Housz-Oro","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Assistance Publique\u2013H\u00f4pitaux de Paris, Henri Mondor Hospital, Cr\u00e9teil, France"},{"name":"EA 7379 EpiDermE (Epidemiologie en Dermatologie et Evaluation des Th\u00e9rapeutiques), Universit\u00e9 Paris\u2013Est Cr\u00e9teil Val de Marne, Cr\u00e9teil, France"},{"name":"Referral Center for Toxic Bullous Diseases, Cr\u00e9teil, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabine","family":"Grootenboer-Mignot","sequence":"additional","affiliation":[{"name":"Department of Immunology, Assistance Publique\u2013H\u00f4pitaux de Paris, Bichat Hospital, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Wolkenstein","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Assistance Publique\u2013H\u00f4pitaux de Paris, Henri Mondor Hospital, Cr\u00e9teil, France"},{"name":"EA 7379 EpiDermE (Epidemiologie en Dermatologie et Evaluation des Th\u00e9rapeutiques), Universit\u00e9 Paris\u2013Est Cr\u00e9teil Val de Marne, Cr\u00e9teil, France"},{"name":"Referral Center for Toxic Bullous Diseases, Cr\u00e9teil, France"},{"name":"Universit\u00e9 Paris\u2013Est Cr\u00e9teil Val de Marne, Cr\u00e9teil, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Chosidow","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Assistance Publique\u2013H\u00f4pitaux de Paris, Henri Mondor Hospital, Cr\u00e9teil, France"},{"name":"EA 7379 EpiDermE (Epidemiologie en Dermatologie et Evaluation des Th\u00e9rapeutiques), Universit\u00e9 Paris\u2013Est Cr\u00e9teil Val de Marne, Cr\u00e9teil, France"},{"name":"Referral Center for Toxic Bullous Diseases, Cr\u00e9teil, France"},{"name":"Universit\u00e9 Paris\u2013Est Cr\u00e9teil Val de Marne, Cr\u00e9teil, France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","container-title":["JAMA Dermatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/archderm.jamanetwork.com\/article.aspx?doi=10.1001\/jamadermatol.2017.5889","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,4,11]],"date-time":"2018-04-11T17:23:40Z","timestamp":1523467420000},"score":1,"resource":{"primary":{"URL":"http:\/\/archderm.jamanetwork.com\/article.aspx?doi=10.1001\/jamadermatol.2017.5889"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4,1]]},"references-count":0,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018,4,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamadermatol.2017.5889","relation":{},"ISSN":["2168-6068"],"issn-type":[{"value":"2168-6068","type":"print"}],"subject":[],"published":{"date-parts":[[2018,4,1]]}}}